ATE389015T1 - Paget knochenkrankheit - Google Patents

Paget knochenkrankheit

Info

Publication number
ATE389015T1
ATE389015T1 AT02748529T AT02748529T ATE389015T1 AT E389015 T1 ATE389015 T1 AT E389015T1 AT 02748529 T AT02748529 T AT 02748529T AT 02748529 T AT02748529 T AT 02748529T AT E389015 T1 ATE389015 T1 AT E389015T1
Authority
AT
Austria
Prior art keywords
bone disease
paget bone
paget
bone
paget disease
Prior art date
Application number
AT02748529T
Other languages
English (en)
Inventor
Jacques Brown
Vincent Raymond
Jean Morissette
Nancy Laurin
Original Assignee
G R M O Groupe De Rech En Mala
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by G R M O Groupe De Rech En Mala filed Critical G R M O Groupe De Rech En Mala
Application granted granted Critical
Publication of ATE389015T1 publication Critical patent/ATE389015T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Rheumatology (AREA)
  • Public Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT02748529T 2001-07-30 2002-07-30 Paget knochenkrankheit ATE389015T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30813501P 2001-07-30 2001-07-30

Publications (1)

Publication Number Publication Date
ATE389015T1 true ATE389015T1 (de) 2008-03-15

Family

ID=23192698

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02748529T ATE389015T1 (de) 2001-07-30 2002-07-30 Paget knochenkrankheit

Country Status (10)

Country Link
US (1) US7479368B2 (de)
EP (1) EP1414960B1 (de)
AT (1) ATE389015T1 (de)
AU (1) AU2002319062B2 (de)
CA (1) CA2456037C (de)
DE (1) DE60225562T2 (de)
ES (1) ES2300453T3 (de)
NZ (1) NZ531454A (de)
PT (1) PT1414960E (de)
WO (1) WO2003012134A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE421532T1 (de) 2002-05-14 2009-02-15 Jaekyoon Shin Die rolle von p62 bei altersbedingten erkrankungen
JP2006501153A (ja) * 2002-05-23 2006-01-12 パーデュー・リサーチ・ファウンデーション 診断及び治療用標的としての低分子量タンパク質チロシンホスファターゼ（ｌｍｗ−ｐｔｐ）
GB201006197D0 (en) * 2010-04-14 2010-06-02 Univ Edinburgh Genetic markers for PDB
US20130209999A1 (en) * 2011-08-19 2013-08-15 Northwestern University Sqstm1 mutations in amyotrophic lateral sclerosis
CN106061501A (zh) * 2013-12-29 2016-10-26 Cl昂科莱吉有限公司 用于治疗和预防炎症相关疾病的涉及p62/sqstm1的方法和组合物
US20170130272A1 (en) * 2014-05-21 2017-05-11 Consiglio Nazionale Delle Ricerche A Diagnostic Marker For Paget's Disease
WO2016207730A1 (en) * 2015-06-22 2016-12-29 The University Of Oslo Targeting of vaccine antigen to an intracellular compartment
CN117603982B (zh) * 2024-01-22 2024-04-19 中国医学科学院北京协和医院 肌萎缩侧索硬化症的SQSTM1的p.P374TfsTer18突变致病基因及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5610276A (en) * 1991-05-17 1997-03-11 Chiron Corporation Polypeptides and antibodies derived from GAP associated protein, p62
FR2734826B1 (fr) * 1995-06-01 1997-07-04 Rhone Poulenc Rorer Sa Deltap62, ses variants, sequences nucleiques et leurs utilisations
US5962224A (en) * 1995-12-19 1999-10-05 Dana-Farber Cancer Institute Isolated DNA encoding p62 polypeptides and uses therefor

Also Published As

Publication number Publication date
EP1414960B1 (de) 2008-03-12
CA2456037A1 (en) 2003-02-13
US7479368B2 (en) 2009-01-20
DE60225562T2 (de) 2009-04-02
PT1414960E (pt) 2008-04-28
NZ531454A (en) 2006-05-26
WO2003012134A3 (en) 2003-10-09
US20050042611A1 (en) 2005-02-24
DE60225562D1 (de) 2008-04-24
AU2002319062B2 (en) 2008-02-14
CA2456037C (en) 2009-12-15
EP1414960A2 (de) 2004-05-06
WO2003012134A2 (en) 2003-02-13
ES2300453T3 (es) 2008-06-16

Similar Documents

Publication Publication Date Title
NO20050427L (no) Carvedilolfosfatsalter og/eller solvater derav, tilsvarende preparater og/eller behandlingsfremgangsmater
DE60330335D1 (de) Endoskopinformationsprozessor und verarbeitungsmethode
NO2014027I1 (no) Aripiprazol (preparat - krav 1 og 2 i patentet)
PL373333A1 (pl) Stosowanie przeciwciał skierowanych przeciw TNFalfa i innego leku
DK1944040T3 (da) Analysefremgangsmåde for Alzheimers sygdom
FI20145179L (fi) Menetelmä ja laitteisto monitasoiseksi hajautetuksi
DE60237823D1 (de) Medizinisches behandlungsinstrument
DK1368060T3 (da) HMGB1-proteininhibitorer og/eller antagonister til behandlingen af vaskulære sygdomme
ATE350375T1 (de) 17beta-hydroxysteroid dehydrogenase type 3 inhibitoren zur behandlung von androgen- abhängigen erkrankungen
CY2015055I1 (el) Διαλυματα και μεθοδος οφθαλμολογικης διαποτισης
NO20033387D0 (no) Modifiserte antistoffer og fremgangsmåter for anvendelse
IS6999A (is) Mótefni sem blokka prótínið Cripto og notkun þeirra
NO20033086D0 (no) Lineor blokk-kopolymer og fremgangsmate for fremstilling av samme
DE60229337D1 (de) Bildauswertungsverfahren und Mikroskop
FR2846545B1 (fr) Implant d'osteosynthese intramedullaire
CY1107116T1 (el) Νεες κυκλοεξυλ σουλφονες
DE60239627D1 (de) Signalverarbeitungsverfahren und prozessor
DK2380583T3 (da) Små peptider til behandling af Alzheimers sygdom og andre beta-amyloidprotein-fibrillogeneseforstyrrelser
NO20033854D0 (no) N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse
NO20011362D0 (no) Algoritme for hurtige og sensitive databasesøk
DK1537140T3 (da) Nukleinsyre og tilsvarende protein betegnet 161P2F10B, der er anvendelige i behandling og detektering af cancer
DE60225562D1 (de) Paget knochenkrankheit
DE60217539D1 (de) Leichtathletikschuh
NO20034827D0 (no) Bearbeidingshjelpemiddel og fremgangsmåte for bearbeiding av polymerer
FR2840799B1 (fr) Vis d'osteosynthese

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1414960

Country of ref document: EP